Waseem Qasim is Professor of Cell and Gene therapy at the Institute of Child Health, and a consultant immunologist at Great Ormond Street hospital. He trained in Immunology and Paediatric Medicine, and then completed his PhD at University College London. He is researching blood and marrow stem cell transplantation and the application of engineered cell therapies, and heads a research group developing genetic therapies, from basic laboratory development to first-in-human trials. His group has a strong focus on lentiviral technology and gene-editing tools including TALENs and CRISPR/Cas reagents for novel therapeutic applications. He was listed in the Debrett’s 500 list for 2016 and 2017.